Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.57 | N/A |
| PEG Ratio (TTM) | 3.12 | N/A |
| P/S Ratio (TTM) | 2.56 | N/A |
| P/B Ratio (TTM) | 0.74 | N/A |
| P/FCF Ratio (TTM) | 10.75 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.04 | N/A |
| Price to 5YR AVG FCF Ratio | 16.93 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.39% | N/A |
| ROE (TTM) | 4.41% | N/A |
| Net Profit Margin (TTM) | 9.82% | N/A |
| ROIC 5YR AVG | 8.62% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 99.42% | 11.25% | 2.76% |
| Revenue | 31.25% | 8.24% | 5.13% |
| Net Income | 95.35% | 18.14% | 6.42% |
| Cash Flow | 17.41% | 4.66% | 5.43% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 1.00 | N/A |
| Interest Coverage (TTM) | 1.10 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.23 | N/A |
| LTL to 5YR AVG FCF | 5.81 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.99% | N/A |